Skip to main content

Market Overview

55 Stocks Moving In Friday's Mid-Day Session

Share:

Gainers

  • Wellesley Bancorp, Inc. (NASDAQ: WEBK) shares climbed 29.1% to $41.70. Cambridge Trust announced plans to acquire Wellesley Bank for $122 million.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares gained 29.7% to $2.3350 after the company announced additional positive Phase 2a clinical data in Alzheimer's disease at the CTAD 2019.
  • Genesco Inc. (NYSE: GCO) gained 27.4% to $47.07 after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast.
  • Big Lots, Inc. (NYSE: BIG) rose 25.8% to $24.10 after the company reported upbeat results for its third quarter.
  • KLX Energy Services Holdings, Inc. (NASDAQ: KLXE) surged 24.4% to $5.26 after OPEC and OPEC+ agreed to further oil production cuts.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) rose 22.1% to $6.73.
  • Onconova Therapeutics Inc (NASDAQ: ONTX) gained 20.5% to $0.3520 after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.
  • EZCORP, Inc. (NASDAQ: EZPW) rose 19.5% to $6.25 following Q4 earnings.
  • Sierra Oncology Inc (NASDAQ: SRRA) surged 19.1% to $0.4562 after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $1.20 price target.
  • Domo, Inc. (NASDAQ: DOMO) rose 16.7% to $22.76 after the company reported Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
  • Epizyme, Inc. (NASDAQ: EPZM) gained 14.2% to $17.48 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price action from $12 to $22 per share.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) gained 13.7% to $10.07 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
  • The Chemours Company (NYSE: CC) climbed 13.3% to $17.06 on reports stating the House is said to be easing 'Forever chemical' wording.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) rose 12.7% to $4.77 on continued momentum after the company reported the topline Phase 1 data for its LX9211. NOTE: The study showed favorable safety results.
  • Hovnanian Enterprises, Inc. (NYSE: HOV) gained 12.7% to $28.14. Buckingham maintained Hovnanian with a Neutral and raised the price target from $24 to $27.
  • PolarityTE, Inc. (NASDAQ: PTE) surged 12.3% to $2.9081.
  • Ulta Beauty, Inc. (NASDAQ: ULTA) rose 12% to $264.34 after the company reported better-than-expected Q3 EPS results. The company also narrowed its FY19 EPS guidance above analyst estimates.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) climbed 11.4% to $19.96.
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) gained 10.4% to $21.76. Rocket Pharma reported that first patient has been treated in global registrational Phase 2 study of RP-L102 for fanconi anemia.
  • Evolent Health, Inc. (NYSE: EVH) shares climbed 10.3% to $7.37 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
  • Zumiez Inc. (NASDAQ: ZUMZ) rose 10.3% to $33.71 after the company reported stronger-than-expected Q3 results and issued Q4 EPS guidance above analyst estimates.
  • Avadel Pharmaceuticals plc (NASDAQ: AVDL) gained 10% to $6.34.
  • National Beverage Corp. (NASDAQ: FIZZ) climbed 9.6% to $52.89 following Q2 results.
  • Progyny, Inc. (NASDAQ: PGNY) gained 9.6% to $30.54.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) rose 8.6% to $8.08. H.C. Wainwright initiated coverage on Puma Biotechnology with a Buy rating and a $15 price target.
  • The Michaels Companies, Inc. (NASDAQ: MIK) gained 8.4% to $6.59.
  • Signet Jewelers Limited (NYSE: SIG) gained 8.4% to $19.40 on continued strength from Thursday's earnings report. Wells Fargo raised the price target to $16/share but said the company's core fundamental business remains 'pressured.'
  • Realogy Holdings Corp. (NYSE: RLGY) climbed 8% to $10.52 after moving back above the $10 level. Not currently seeing any company-specific news.
  • Cloudera, Inc. (NYSE: CLDR) rose 7.7% to $10.78 after the company reported upbeat quarterly earnings.
  • Tantech Holdings Ltd (NASDAQ: TANH) gained 7.3% to $2.20.
  • Sage Therapeutics, Inc. (NASDAQ: SAGE) rose 7.2% to $64.50 after falling 59.67% on Thursday. SVB Leerink upgraded Sage Therapeutics from Underperform to Market Perform.
  • Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) rose 7.2% to $10.69. Goldman Sachs upgraded Kiniksa Pharmaceuticals from Neutral to Buy and raised the price target from $16 to $18.
  • InMode Ltd. (NASDAQ: INMD) gained 6.7% to $46.50 in sympathy with the overall market amid a rally in US equities following strong November jobs data.
  • Adverum Biotechnologies, Inc. (NASDAQ: ADVM) gained 6.7% to $11.25 in sympathy with the overall market after a rally in US equities following strong November jobs data.
  • Trade Desk Inc (NASDAQ: TTD) rose 5.5% to $253.68. Needham upgraded Trade Desk from Hold to Buy and announced a $325 price target.
  • DocuSign, Inc. (NASDAQ: DOCU) rose 4.1% to $72.36 after reporting better-than-expected Q3 earnings results.

Check out these big penny stock gainers and losers

Losers

  • Correvio Pharma Corp. (NASDAQ: CORV) shares dipped 33.9% to $1.4283.
  • Oyster Point Pharma, Inc. (NASDAQ: OYST) shares fell 16% to $15.51.
  • Yext, Inc. (NYSE: YEXT) fell 15.2% to $14.07 after the company reported worse-than-expected Q3 EPS results and issued weak forecast.
  • IMAC Holdings, Inc. (NASDAQ: IMAC) dropped 13.5% to $1.7296.
  • Liquid Media Group Ltd. (NASDAQ: YVR) dipped 13.3% to $2.55.
  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) fell 10.8% to $2.22 on continued downward momentum after the company priced a 5.2 million ADS offering at $2.50 per ADS.
  • Cortexyme, Inc. (NASDAQ: CRTX) dropped 10.8% to $30.60.
  • PagerDuty, Inc. (NYSE: PD) shares fell 10.3% to $22.41 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 and FY20 EPS guidance below analyst estimates.
  • Zoom Video Communications, Inc. (NASDAQ: ZM) fell 10.3% to $62.51 after the company reported Q3 earnings results. The company also issued Q4 and FY20 guidance.
  • Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dipped 10.2% to $107.54. Intercept announced publication of results from the interim analysis of the Phase 3 REGENERATE study of OCA for the treatment of fibrosis due to NASH in The Lancet.
  • DarioHealth Corp (NASDAQ: DRIO) fell 9.4% to $7.70.
  • China Automotive Systems, Inc. (NASDAQ: CAAS) fell 8.7% to $3.56.
  • Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) dropped 8.4% to $5.25.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) dipped 8.2% to $3.4808.
  • IDT Corporation (NYSE: IDT) fell 8% to $6.90 following Q1 results.
  • Guidewire Software Inc (NYSE: GWRE) fell 6.4% to $111.67 after the company issued Q2 sales guidance below analyst estimates.
  • Weidai Ltd. (NYSE: WEI) fell 5% to $4.24 after declining 10.29% on Thursday.
  • Ciena Corporation (NYSE: CIEN) fell 4.7% to $34.58. UBS downgraded Ciena from Neutral to Sell and lowered the price target from $43 to $31.
  • Xinyuan Real Estate Co., Ltd. (NYSE: XIN) fell 4.4% to $3.7389 following Q3 results.
 

Related Articles (ADVM + ASLN)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com